Research output per year
Research output per year
Fingerprint
Dive into the research topics where ADOLFO DIAZDUQUE is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia
Dalle, I. A., Cortes, J. E., Pinnamaneni, P., Lamothe, B., Duque, A. D., Randhawa, J., Pemmaraju, N., Jabbour, E., Ferrajoli, A., Wierda, W. G., Estrov, Z., Konopleva, M., Ravandi, F., Alvarado, Y., Borthakur, G., Gandhi, V. & Kantarjian, H. M., Sep 1 2018, In: Acta Haematologica. 140, 1, p. 30-39 10 p.Research output: Contribution to journal › Article › peer-review
8 Scopus citations -
Emerging therapies for the treatment of essential thrombocythemia
Diaz, A. E., Scherber, R. M. & Mesa, R. A., Oct 3 2018, In: Expert Opinion on Orphan Drugs. 6, 10, p. 567-575 9 p.Research output: Contribution to journal › Review article › peer-review
-
Pacritinib and its use in the treatment of patients with myelofibrosis who have thrombocytopenia
Diaz, A. E. & Mesa, R. A., Apr 2018, In: Future Oncology. 14, 9, p. 797-807 11 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations